CLYM Competitors & Alternatives
Compare Climb Bio Inc with similar stocks in the same industry
Biotechnology
CLYM
Main Stock$10.19
Tradestie Score
48
Market Cap
$133.50M
Analyst Upside
+170.9%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
ANL
ANL
|
$10.58
|
$681.33M | - | 62 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.21
|
$665.30M | 11.2 | 48 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.39
|
$626.91M | - | 45 | Compare |
|
SVRA
Savara Inc.
|
$4.22
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.32
|
$552.46M | - | 53 | Compare |
|
VSTM
Verastem, Inc.
|
$10.04
|
$541.60M | - | 39 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.53
|
$540.97M | - | 61 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.81
|
$529.35M | 11.2 | 56 | Compare |
More CLYM Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry